EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolic Impact of Frailty Changes Diabetes Trajectory

Alan J Sinclair, Ahmed H Abdelhafiz

Metabolites · 16.02.2023 · 13 (2) · 295

DOI: 10.3390/metabo13020295 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 16.02.2023. Verfasst von Alan J Sinclair und 1 weiteren Autor:innen. Beteiligte Einrichtung: Foundation for Diabetes Research in Older People (fDROP), King's College, London WC2R 2LS, UK. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus prevalence increases with increasing age. In older people with diabetes, frailty is a newly emerging and significant complication. Frailty induces body composition changes that influence the metabolic state and affect diabetes trajectory. Frailty appears to have a wide metabolic spectrum, which can present with an anorexic malnourished phenotype and a sarcopenic obese phenotype. The sarcopenic obese phenotype individuals have significant loss of muscle mass and increased visceral fat. This phenotype is characterised by increased insulin resistance and a synergistic increase in the cardiovascular risk more than that induced by obesity or sarcopenia alone. Therefore, in this phenotype, the trajectory of diabetes is accelerated, which needs further intensification of hypoglycaemic therapy and a focus on cardiovascular risk reduction. Anorexic malnourished individuals have significant weight loss and reduced insulin resistance. In this phenotype, the trajectory of diabetes is decelerated, which needs deintensification of hypoglycaemic therapy and a focus on symptom control and quality of life. In the sarcopenic obese phenotype, the early use of sodium-glucose transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists is reasonable due to their weight loss and cardio–renal protection properties. In the malnourished anorexic phenotype, the early use of long-acting insulin analogues is reasonable due to their weight gain and anabolic properties, regimen simplicity and the convenience of once-daily administration.

Schlagwörter

Stichwörter der Autor:innen

diabetes mellitusfrailtyhypoglycaemic therapymanagementolder people

Autor:innen und Institutionen

  • Foundation for Diabetes Research in Older People (fDROP), King's College, London WC2R 2LS, UK.
  • Department of Geriatric Medicine Rotherham General Hospital, Rotherham S60 2UD, UK.

Zitieren

APA

Sinclair, A. J., & Abdelhafiz, A. H. (2023). Metabolic Impact of Frailty Changes Diabetes Trajectory. Metabolites, 13(2), 295. https://doi.org/10.3390/metabo13020295

Vancouver

Sinclair AJ, Abdelhafiz AH. Metabolic Impact of Frailty Changes Diabetes Trajectory. Metabolites. 2023;13(2):295. doi:10.3390/metabo13020295

BibTeX
@article{Sinclair2023,
  author = {Sinclair, Alan J and Abdelhafiz, Ahmed H},
  title = {Metabolic Impact of Frailty Changes Diabetes Trajectory},
  journal = {Metabolites},
  year = {2023},
  volume = {13},
  number = {2},
  pages = {295},
  doi = {10.3390/metabo13020295}
}
Kostenlos starten →